Related Experiment Video
Updated: Aug 6, 2026

Photo-Induced Cross-Linking of Unmodified Proteins (PICUP) Applied to Amyloidogenic Peptides
Published on: January 12, 2009
Photo-induced crosslinking of prion protein oligomers and prions
Niklas Piening1, Petra Weber, Tobias Högen
1Zentrum für Neuropathologie und Prionforschung, Ludwig-Maximilians-Universität München, Feodor-Lynen-Strasse 23, 81377 München, Germany.
Abstract:
Prion diseases are caused by a unique type of infectious agent, which is thought to consist of a misfolded beta-sheeted form of the alpha-helical cellular prion protein (PrPC). This misfolded isoform (PrPSc) tends to form insoluble amyloid-like aggregates, impeding classical structural analysis by X-ray crystallography or NMR. Intermolecular crosslinking may provide a means of stabilizing notoriously elusive oligomers for further analysis and may be used for analyzing aggregate architecture by characterising intermolecular contact sites. Using a photo-induced crosslinking method (PICUP), aggregates of recombinant PrP (rPrP) and PrPSc were linked at interacting surfaces via amino acid side chains. The degree of crosslinking within PrP aggregates was adjustable using varying light intensities and could efficiently be monitored by fluorescence correlation spectroscopy. Specific intermolecular crosslinking of PrPSc molecules was achieved even in crude brain homogenate. Functional studies showed that stabilized aggregates of rPrP did not loose their capacity to induce further protein aggregation and crosslinking of PrPSc did not alter significantly the level of infectivity, indicating that photo-induced covalent linkage of PrPSc does not destruct surfaces important for prion propagation.
Insights
Photo-induced crosslinking stabilizes prion protein aggregates for structural analysis. This method preserves prion infectivity, aiding research into neurodegenerative diseases.
Area of Science:
- Biochemistry
- Structural Biology
- Neuroscience
Background:
- Prion diseases stem from misfolded prion proteins (PrPSc), which form insoluble aggregates.
- These aggregates resist traditional structural analysis methods like X-ray crystallography and NMR.
- Stabilizing these elusive oligomers is crucial for understanding their structure and function.
Purpose of the Study:
- To investigate photo-induced crosslinking (PICUP) as a method to stabilize prion protein aggregates.
- To analyze the architecture of prion aggregates and identify intermolecular contact sites.
- To assess the impact of crosslinking on prion infectivity and aggregation-inducing capacity.
Main Methods:
- Utilized photo-induced crosslinking (PICUP) to covalently link interacting amino acid side chains in prion protein aggregates.
- Employed varying light intensities to control the degree of crosslinking.
- Monitored crosslinking efficiency using fluorescence correlation spectroscopy.
- Performed functional studies on crosslinked recombinant PrP (rPrP) and PrPSc in brain homogenates.
Main Results:
- PICUP successfully crosslinked recombinant PrP (rPrP) and disease-associated PrPSc aggregates.
- The degree of crosslinking was controllable via light intensity and monitored by fluorescence correlation spectroscopy.
- Specific intermolecular crosslinking of PrPSc was achieved even in crude brain homogenates.
- Stabilized rPrP aggregates retained their ability to induce further protein aggregation.
- Crosslinking of PrPSc did not significantly alter prion infectivity levels.
Conclusions:
- Photo-induced crosslinking is an effective method for stabilizing elusive prion protein aggregates.
- This technique allows for the analysis of aggregate architecture without compromising prion infectivity.
- PICUP offers a valuable tool for studying the structural basis of prion propagation and developing therapeutic strategies.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

